Tscan TherapeuticsTCRX
13F holders, Q1 2024 (March 31)66holders
3famous investors
$7.94avg. 13F price*
At the end of Q1 2024, 66 institutions reported holding Tscan Therapeutics Inc. (TCRX) in their 13F filings. The largest holders were Lynx1 Capital Management LP ($41.5M), EcoR1 Capital, LLC ($39.7M) and Adage Capital Partners Gp, L.L.C. ($31.0M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Tscan Therapeutics Inc.
- CUSIP
- 89854M101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 17 | $7.8M |
| Exits | 5 | $534K |
Ownership 66 holders
| Lynx1 Capital Management LP | 10.68% | No change | 5,224,600 | $41.5M |
| EcoR1 Capital, LLC | 1.01% | No change | 5,000,000 | $39.7M |
| Adage Capital Partners Gp, L.L.C. | 0.06% | No change | 3,900,000 | $31.0M |
| BVF Inc. | 0.65% | No change | 2,989,474 | $23.7M |
| Baker Bros. Advisors LP | 0.28% | No change | 2,784,792 | $22.1M |
| Propel Bio Management, LLC | 9.65% | No change | 2,087,139 | $16.6M |
| Vanguard Group Inc. | 0.00% | Add +1.1% | 1,808,152 | $14.4M |
| BlackRock Inc. | 0.00% | Add +1.6% | 1,699,213 | $13.5M |
| Deer Management Co. LLC | 1.79% | Reduce 0.0% | 1,245,504 | $9.9M |
| Alphabet Inc. | 0.34% | No change | 1,077,080 | $8.6M |
| Simplify Asset Management Inc. | 0.80% | No change | 1,046,916 | $8.3M |
| DC Funds, LP | 48.34% | No change | 630,000 | $5.0M |
| Invesco Ltd. | 0.00% | New | 488,415 | $3.9M |
| Geode Capital Management, LLC | 0.00% | Add +5.7% | 413,779 | $3.3M |
| Millennium Management | 0.00% | Add +295.8% | 392,115 | $3.1M |
| Laurion Capital Management LP | 0.08% | Add +500.1% | 362,484 | $2.9M |
| Susquehanna International Group, LLP | 0.00% | Add +186.6% | 297,902 | $2.4M |
| Goldman Sachs Group Inc. | 0.00% | Add +759.0% | 260,148 | $2.1M |
| Morgan Stanley | 0.00% | Reduce -4.6% | 223,894 | $1.8M |
| Tocqueville Asset Management L.P. | 0.03% | New | 212,200 | $1.7M |
| Aberdeen Group plc | 0.00% | No change | 200,000 | $1.6M |
| Marshall Wace, LLP | 0.00% | Add +72.9% | 191,171 | $1.5M |
| Jane Street Group, LLC | 0.00% | Add +83.1% | 153,133 | $1.2M |
| Qube Research & Technologies Ltd | 0.00% | Add +79.4% | 143,536 | $1.1M |
| State Street Corp. | 0.00% | Add +121.0% | 135,000 | $1.1M |
| Citigroup Inc. | 0.00% | Add +59.8% | 116,921 | $928K |
| Stifel Financial Corp. | 0.00% | Reduce -15.8% | 101,400 | $805K |
| NewEdge Wealth, LLC | 0.02% | No change | 91,463 | $791K |
| Man Group plc | 0.00% | Add +53.4% | 77,339 | $614K |
| Northern Trust Corp. | 0.00% | Add +7.5% | 76,960 | $611K |
| JPMorgan Chase & Co. | 0.00% | Add +101.7% | 67,013 | $532K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -28.3% | 63,300 | $503K |
| Walleye Capital LLC | 0.01% | Add +195.2% | 52,478 | $417K |
| Marathon Trading Investment Management LLC | 0.16% | New | 51,000 | $405K |
| Renaissance Technologies | 0.00% | Add +116.6% | 47,000 | $373K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +68.8% | 44,308 | $352K |
| Balyasny Asset Management L.P. | 0.00% | Reduce -8.8% | 41,942 | $333K |
| Two Sigma Investments, LP | 0.00% | New | 37,747 | $300K |
| ExodusPoint Capital Management, LP | 0.00% | Reduce -44.1% | 35,661 | $283K |
| DC Investments Management, LLC | 0.24% | No change | 35,563 | $282K |
| HRT Financial LP | 0.00% | New | 34,789 | $276K |
| Brevan Howard Capital Management LP | 0.03% | New | 34,578 | $275K |
| American Century Companies Inc. | 0.00% | Add +49.6% | 31,885 | $253K |
| Bank of America Corp. | 0.00% | Reduce -20.2% | 30,179 | $240K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | Add +62.9% | 24,446 | $194K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 22,104 | $176K |
| Pale Fire Capital SE | 0.02% | No change | 21,573 | $171K |
| Letko, Brosseau & Associates Inc. | 0.00% | No change | 20,700 | $164K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.04% | New | 19,736 | $157K |
| Cannon Global Investment Management, LLC | 0.37% | New | 17,500 | $139K |
| Credit Suisse AG/ | 0.00% | New | 17,366 | $138K |
| Privium Fund Management (UK) Ltd | 0.06% | No change | 15,825 | $127K |
| OMERS ADMINISTRATION Corp | 0.00% | New | 14,200 | $113K |
| Jefferies Financial Group Inc. | 0.00% | New | 12,200 | $97K |
| Citadel Advisors | 0.00% | New | 11,432 | $91K |
| CTC Alternative Strategies, Ltd. | 0.05% | New | 11,000 | $87K |
| Jump Financial, LLC | 0.00% | New | 10,291 | $82K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 10,061 | $80K |
| Aries Wealth Management | 0.03% | No change | 10,000 | $79K |
| Waldron Private Wealth LLC | 0.00% | No change | 10,000 | $79K |
| Lazard Asset Management LLC | 0.00% | Reduce -36.0% | 2,551 | $19K |
| UBS Group AG | 0.00% | Add +33.5% | 1,901 | $15K |
| Wells Fargo & Company | 0.00% | Add +1.7% | 306 | $2K |
| Federated Hermes, Inc. | 0.00% | New | 56 | $445 |
| Atlas Capital Advisors Inc. | 0.00% | Reduce -98.0% | 18 | $142 |
| Macquarie Group Ltd. | 0.00% | New | 1,618 | $13 |
"% of holder's portfolio" is TCRX's weight in each manager's 13F, not the share of Tscan Therapeutics Inc. the manager owns.